BMS to lay off 516 employees at its Lawrence Township facility
Bristol Myers Squibb (BMS) is set to lay off 516 employees at its Lawrence Township, New Jersey, facility, with the reductions occurring across multiple dates from May 9, 2025, through March 27, 2026.
This information comes from a Worker Adjustment and Retraining Notification (WARN) notice filed with the New Jersey Department of Labor. The layoffs are part of BMS’s broader cost-saving strategy aimed at reducing expenses by $1.5 billion by the end of 2025.
The Lawrence Township site serves as BMS’s corporate headquarters and includes facilities for commercial and late-stage development work. The company has indicated that these workforce reductions are part of efforts to optimize operations and prioritize investments in innovative medicines. A BMS spokesperson stated that supporting employees throughout the transition process is a top priority.
In addition to the New Jersey layoffs, BMS has disclosed plans to cut 57 jobs at its Redwood City, California, research facility, with those reductions taking effect by April 22, 2025.
These layoffs are part of a series of workforce reductions by BMS in recent years, reflecting the company’s ongoing efforts to streamline operations and focus on key therapeutic areas. The company has filed multiple WARN notices in various states, indicating a pattern of restructuring to align with its strategic objectives.
